BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 28161936)

  • 1. Prevalence of Mutations in Discoidin Domain-Containing Receptor Tyrosine Kinase 2 (DDR2) in Squamous Cell Lung Cancers in Korean Patients.
    Lee MS; Jung EA; An SB; Kim YJ; Oh DY; Song JY; Um SW; Han J; Choi YL
    Cancer Res Treat; 2017 Oct; 49(4):1065-1076. PubMed ID: 28161936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational Landscape of DDR2 Gene in Lung Squamous Cell Carcinoma Using Next-generation Sequencing.
    Ricordel C; Lespagnol A; Llamas-Gutierrez F; de Tayrac M; Kerjouan M; Fievet A; Hamdi-Rozé H; Aliouat A; Desrues B; Mosser J; Léna H
    Clin Lung Cancer; 2018 Mar; 19(2):163-169.e4. PubMed ID: 29129434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional analysis of Discoidin domain receptor 2 mutation and expression in squamous cell lung cancer.
    Kobayashi-Watanabe N; Sato A; Watanabe T; Abe T; Nakashima C; Sueoka E; Kimura S; Sueoka-Aragane N
    Lung Cancer; 2017 Aug; 110():35-41. PubMed ID: 28676216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of KRAS, DDR2, and TP53 gene mutations in lung cancer: An analysis of Iranian patients.
    Fathi Z; Mousavi SAJ; Roudi R; Ghazi F
    PLoS One; 2018; 13(7):e0200633. PubMed ID: 30048458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional Analyses of Mutations in Receptor Tyrosine Kinase Genes in Non-Small Cell Lung Cancer: Double-Edged Sword of DDR2.
    Terashima M; Togashi Y; Sato K; Mizuuchi H; Sakai K; Suda K; Nakamura Y; Banno E; Hayashi H; De Velasco MA; Fujita Y; Tomida S; Mitsudomi T; Nishio K
    Clin Cancer Res; 2016 Jul; 22(14):3663-71. PubMed ID: 26826182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitive methods for detection of the S768R substitution in exon 18 of the DDR2 gene in patients with central nervous system metastases of non-small cell lung cancer.
    Nicoś M; Powrózek T; Krawczyk P; Jarosz B; Pająk B; Sawicki M; Kucharczyk K; Trojanowski T; Milanowski J
    Med Oncol; 2014 Oct; 31(10):176. PubMed ID: 25173530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel driver mutations of the discoidin domain receptor 2 (DDR2) gene in squamous cell lung cancer of Chinese patients.
    Miao L; Wang Y; Zhu S; Shi M; Li Y; Ding J; Yang J; Ye Q; Cai H; Zhang D; Liu H; Song Y
    BMC Cancer; 2014 May; 14():369. PubMed ID: 24885564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphoproteomics of collagen receptor networks reveals SHP-2 phosphorylation downstream of wild-type DDR2 and its lung cancer mutants.
    Iwai LK; Payne LS; Luczynski MT; Chang F; Xu H; Clinton RW; Paul A; Esposito EA; Gridley S; Leitinger B; Naegle KM; Huang PH
    Biochem J; 2013 Sep; 454(3):501-13. PubMed ID: 23822953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in the DDR2 kinase gene identify a novel therapeutic target in squamous cell lung cancer.
    Hammerman PS; Sos ML; Ramos AH; Xu C; Dutt A; Zhou W; Brace LE; Woods BA; Lin W; Zhang J; Deng X; Lim SM; Heynck S; Peifer M; Simard JR; Lawrence MS; Onofrio RC; Salvesen HB; Seidel D; Zander T; Heuckmann JM; Soltermann A; Moch H; Koker M; Leenders F; Gabler F; Querings S; Ansén S; Brambilla E; Brambilla C; Lorimier P; Brustugun OT; Helland A; Petersen I; Clement JH; Groen H; Timens W; Sietsma H; Stoelben E; Wolf J; Beer DG; Tsao MS; Hanna M; Hatton C; Eck MJ; Janne PA; Johnson BE; Winckler W; Greulich H; Bass AJ; Cho J; Rauh D; Gray NS; Wong KK; Haura EB; Thomas RK; Meyerson M
    Cancer Discov; 2011 Jun; 1(1):78-89. PubMed ID: 22328973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adaptive responses to dasatinib-treated lung squamous cell cancer cells harboring DDR2 mutations.
    Bai Y; Kim JY; Watters JM; Fang B; Kinose F; Song L; Koomen JM; Teer JK; Fisher K; Chen YA; Rix U; Haura EB
    Cancer Res; 2014 Dec; 74(24):7217-7228. PubMed ID: 25348954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DDR2 overexpression in oral squamous cell carcinoma is associated to lymph node metastasis.
    Velmurugan BK; Chang WH; Chung CM; Yeh CM; Lee CH; Yeh KT; Lin SH
    Cancer Biomark; 2018; 22(4):747-753. PubMed ID: 29945346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discoidin domain receptor 2 signaling networks and therapy in lung cancer.
    Payne LS; Huang PH
    J Thorac Oncol; 2014 Jun; 9(6):900-4. PubMed ID: 24828669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective genetic profiling of squamous cell lung cancer and adenosquamous carcinoma in Japanese patients by multitarget assays.
    Kenmotsu H; Serizawa M; Koh Y; Isaka M; Takahashi T; Taira T; Ono A; Maniwa T; Takahashi S; Mori K; Endo M; Abe M; Hayashi I; Nakajima T; Ohde Y; Yamamoto N
    BMC Cancer; 2014 Oct; 14():786. PubMed ID: 25348872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for EGFR and KRAS mutations in non-small cell lung carcinomas using DNA extraction by hydrothermal pressure coupled with PCR-based direct sequencing.
    Liu Y; Wu BQ; Zhong HH; Hui P; Fang WG
    Int J Clin Exp Pathol; 2013; 6(9):1880-9. PubMed ID: 24040454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TWIST1 induces expression of discoidin domain receptor 2 to promote ovarian cancer metastasis.
    Grither WR; Divine LM; Meller EH; Wilke DJ; Desai RA; Loza AJ; Zhao P; Lohrey A; Longmore GD; Fuh KC
    Oncogene; 2018 Mar; 37(13):1714-1729. PubMed ID: 29348456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DDR2 polymorphisms and mRNA expression in lung cancers of Japanese patients.
    Sasaki H; Shitara M; Yokota K; Okuda K; Hikosaka Y; Moriyama S; Yano M; Fujii Y
    Oncol Lett; 2012 Jul; 4(1):33-37. PubMed ID: 22807955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers.
    Shigematsu H; Lin L; Takahashi T; Nomura M; Suzuki M; Wistuba II; Fong KM; Lee H; Toyooka S; Shimizu N; Fujisawa T; Feng Z; Roth JA; Herz J; Minna JD; Gazdar AF
    J Natl Cancer Inst; 2005 Mar; 97(5):339-46. PubMed ID: 15741570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NSCLC Driven by DDR2 Mutation Is Sensitive to Dasatinib and JQ1 Combination Therapy.
    Xu C; Buczkowski KA; Zhang Y; Asahina H; Beauchamp EM; Terai H; Li YY; Meyerson M; Wong KK; Hammerman PS
    Mol Cancer Ther; 2015 Oct; 14(10):2382-2389. PubMed ID: 26206333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discoidin Domain Receptor 2: A New Target in Cancer.
    Xu X; Yu T; Wang Z
    Oncol Res Treat; 2022; 45(4):205-215. PubMed ID: 35073544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrative and comparative genomic analysis of lung squamous cell carcinomas in East Asian patients.
    Kim Y; Hammerman PS; Kim J; Yoon JA; Lee Y; Sun JM; Wilkerson MD; Pedamallu CS; Cibulskis K; Yoo YK; Lawrence MS; Stojanov P; Carter SL; McKenna A; Stewart C; Sivachenko AY; Oh IJ; Kim HK; Choi YS; Kim K; Shim YM; Kim KS; Song SY; Na KJ; Choi YL; Hayes DN; Kim J; Cho S; Kim YC; Ahn JS; Ahn MJ; Getz G; Meyerson M; Park K
    J Clin Oncol; 2014 Jan; 32(2):121-8. PubMed ID: 24323028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.